MAGP-2: An Extracellular Factor Shown to have Pro-Angiogenic Properties in vivo

Background
Excessive angiogenesis has emerged as an essential feature of tumor development and appears to be regulated in part by extracellular matrix proteins. Scientists at National Jewish Health have identified an extracellular matrix protein (designated MAGP-2) that acts as a pro-angiogenic agent in vivo.

Potential Applications

A target for inhibiting angiogenesis in cancer and other angiogenesis-dependent diseases